Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander P Cole

Showing results (131-140 of 210) with videos related to

Pageof 21
Sort By:
The Journal of Urology|January 12, 2019
Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care RedesignDavid F Friedlander, Nicolas von Landenberg, Björn Löppenberg, et al.
International Urology and Nephrology|September 9, 2025
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970-2024)Boyuan Xiao, Zhiyu Qian, Andrea Piccolini, et al.
Cancer|June 5, 2024
A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in MassachusettsMuhieddine Labban, Benjamin V Stone, Grant L Steele, et al.
Urology Practice|July 27, 2023
Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National SurveyBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urologic Oncology|November 25, 2017
Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapyNicolas von Landenberg, Jacqueline M Speed, Alexander P Cole, et al.
Urologic Oncology|May 7, 2019
The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?Marieke J Krimphove, Alexander P Cole, David F Friedlander, et al.
Clinical Genitourinary Cancer|August 29, 2025
Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database StudyAndrea Piccolini, Stephan M Korn, Zhiyu Qian, et al.
Cancer|May 17, 2021
Racial differences in the treatment and outcomes for prostate cancer in MassachusettsAlexander P Cole, Peter Herzog, Hari S Iyer, et al.
Urologic Oncology|October 3, 2018
Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomySebastian Berg, Alexander P Cole, Sean A Fletcher, et al.
Urologic Oncology|December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patientsMaxine Sun, Maya Marchese, David F Friedlander, et al.
Pageof 21

Showing results (131-140 of 210) with videos related to

Sort By:
Pageof 21
The Journal of Urology|January 12, 2019
Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care RedesignDavid F Friedlander, Nicolas von Landenberg, Björn Löppenberg, et al.
International Urology and Nephrology|September 9, 2025
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970-2024)Boyuan Xiao, Zhiyu Qian, Andrea Piccolini, et al.
Cancer|June 5, 2024
A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in MassachusettsMuhieddine Labban, Benjamin V Stone, Grant L Steele, et al.
Urology Practice|July 27, 2023
Predictors of Financial Toxicity Among United States Prostate Cancer Survivors: Results From a National SurveyBenjamin V Stone, Muhieddine Labban, Dejan K Filipas, et al.
Urologic Oncology|November 25, 2017
Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapyNicolas von Landenberg, Jacqueline M Speed, Alexander P Cole, et al.
Urologic Oncology|May 7, 2019
The current landscape of low-value care in men diagnosed with prostate cancer: what is the role of individual hospitals?Marieke J Krimphove, Alexander P Cole, David F Friedlander, et al.
Clinical Genitourinary Cancer|August 29, 2025
Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database StudyAndrea Piccolini, Stephan M Korn, Zhiyu Qian, et al.
Cancer|May 17, 2021
Racial differences in the treatment and outcomes for prostate cancer in MassachusettsAlexander P Cole, Peter Herzog, Hari S Iyer, et al.
Urologic Oncology|October 3, 2018
Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomySebastian Berg, Alexander P Cole, Sean A Fletcher, et al.
Urologic Oncology|December 14, 2020
Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patientsMaxine Sun, Maya Marchese, David F Friedlander, et al.
Pageof 21